Medicare Enrolled
Dr. Joggy George, M.D.
Internal Medicine · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. George from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. George? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. George
Dr. Joggy George is an internal medicine in Houston, TX, with 18 years in practice. Based on federal Medicare data, Dr. George performed 4,322 Medicare services across 1,790 unique beneficiaries.
Between the years covered by Open Payments, Dr. George received a total of $338,883 from 73 pharmaceutical and/or device companies across 1260 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. George is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 8% volume in TX$ $338,883 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,322
Medicare services
Top 8% in TX for internal medicine
1,790
Unique beneficiaries
$124
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~240 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity | 1,629 | $96 | $250 |
| Critical care, first 30-74 min | 491 | $173 | $400 |
| Office visit, established patient (30-39 min) | 416 | $95 | $226 |
| Electrocardiogram (EKG), 12-lead | 357 | $12 | $84 |
| Echocardiogram, transthoracic | 270 | $153 | $966 |
| Regadenoson injection (Lexiscan) for heart stress test | 236 | $21 | $31 |
| Evaluation of lower heart chamber assist device | 188 | $32 | $498 |
| Hospital follow-up visit, moderate complexity | 98 | $64 | $200 |
| Office visit, established patient, complex (40-54 min) | 90 | $136 | $349 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 65 | $55 | $591 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 64 | $10 | $244 |
| Ultrasonic guidance for blood vessel access | 61 | $12 | $470 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 54 | $1,962 | $4,950 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 54 | $22 | $187 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 54 | $651 | $830 |
| New patient office visit (45-59 min) | 40 | $131 | $356 |
| Ultrasound of both sides of head and neck blood flow | 26 | $151 | $619 |
| Office visit, established patient (20-29 min) | 26 | $55 | $172 |
| Nuclear medicine study of heart muscle blood flow by pet | 25 | $148 | $200 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 20 | $214 | $825 |
| Coronary stent placement | 16 | $430 | $4,797 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 16 | $143 | $1,500 |
| Cardiac catheterization | 13 | $182 | $2,442 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $288 | $4,393 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.9% high complexity
9.4% medium
83.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$338,883
Total received (2018-2024)
Avg $48,412/year across 7 years
Top 0% in TX for internal medicine
73
Companies
1,260
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$310,819 (91.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,626 (7.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,438 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$56,260
2023$22,236
2022$20,235
2021$48,126
2020$34,410
2019$44,356
2018$113,262
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$67,567
AstraZeneca Pharmaceuticals LP
$60,181
Lexicon Pharmaceuticals, Inc.
$58,718
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$55,711
ABIOMED
$42,068
PFIZER INC.
$24,857
Abbott Laboratories
$6,376
Lundbeck LLC
$5,538
Medtronic Vascular, Inc.
$3,583
Inari Medical, Inc.
$1,094
Janssen Pharmaceuticals, Inc
$1,090
Actelion Pharmaceuticals US, Inc.
$1,082
Medtronic, Inc.
$1,031
Amgen Inc.
$1,028
Impulse Dynamics (USA) Inc.
$882
Cardiovascular Systems Inc.
$829
E.R. Squibb & Sons, L.L.C.
$648
Boston Scientific Corporation
$620
Merck Sharp & Dohme LLC
$581
Novo Nordisk Inc
$554
CVRx, Inc.
$423
Esperion Therapeutics, Inc.
$312
Boehringer Ingelheim Pharmaceuticals, Inc.
$285
Penumbra, Inc.
$285
Bayer Healthcare Pharmaceuticals Inc.
$273
Chiesi USA, Inc.
$231
Saranas, Inc.
$183
CHIESI USA, INC.
$164
ATRICURE, INC.
$159
BOSTON SCIENTIFIC CORPORATION
$144
Bolton Medical Inc
$138
Edwards Lifesciences Corporation
$134
Alnylam Pharmaceuticals Inc.
$128
Bayer HealthCare Pharmaceuticals Inc.
$126
BIOTRONIK INC.
$125
AtriCure, Inc.
$113
Akcea Therapeutics, Inc.
$110
AngioDynamics, Inc.
$106
Daiichi Sankyo Inc.
$105
SCPHARMACEUTICALS INC.
$94
iRhythm Technologies, Inc.
$86
SANOFI-AVENTIS U.S. LLC
$85
ZOLL Circulation Inc
$84
Gilead Sciences, Inc.
$79
Kiniksa Pharmaceuticals International, plc
$76
PORTOLA PHARMACEUTICALS, INC.
$75
Siemens Medical Solutions USA, Inc.
$67
Astellas Pharma US Inc
$60
Tactile Systems Technology Inc
$53
Endologix LLC
$45
Kiniksa Pharmaceuticals, Ltd.
$44
Cleerly, Inc.
$37
HEARTFLOW, INC.
$33
Arbor Pharmaceuticals, Inc.
$32
PROCYRION, INC.
$30
Surmodics, Inc.
$27
Inspire Medical Systems, Inc.
$26
W. L. Gore & Associates, Inc.
$20
Teleflex LLC
$20
Kestra Medical Technology Services, Inc.
$20
Itamar Medical Inc
$20
Endologix, LLC
$19
Amarin Pharma Inc.
$18
United Therapeutics Corporation
$17
G Medical Diagnostic Services, Inc.
$16
Preventice Services, LLC
$16
ARBOR PHARMACEUTICALS, INC.
$16
HeartFlow, Inc.
$16
Lilly USA, LLC
$15
Avinger Inc.
$15
Sandoz Inc.
$15
Bardy Diagnostics, Inc.
$12
Vifor Pharma, Inc.
$12
Top 3 companies account for 55.0% of total payments
Associated products mentioned in payments ›
AFX · AFX2 Bifurcated Endograft System · ALPHAVAC · AORTIX SYSTEM · ATRICLIP LAA EXCLUSION SYSTEM · Accent Pacemaker · Adempas · Advisa · AlphaVac · AngioVac · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BELSOMRA · BEVYXXA · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CLEVIPREX · CLEVIPREX 50MG/100ML · CONFIRM RX · COREVALVE EVOLUT R · Cardiac Monitoring Suite · CardioMEMS HF System · CareLink · Carnation Ambulatory Monitor · Catheter - GuideLiner · Cleerly Ischemia · ClosureFast · Confirm Rx · Connectivity and Remote care · CorPath GRX · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DRAGONFLY OPSTAR · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · ELUVIA · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · EkoSonic · Ellipse ICD · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · Fortify Assura · GENERAL THERAPIES · GENERAL THROMBECTOMY · GENERAL - THROMBECTOMY · GENERAL - VASCULAR ACCESS · GORE CARDIOFORM Septal Occluder · Grafts · HEARTMATE TOUCH · HeartMate 3 Left Ventricular Assist Device · HeartMate 3 Left Ventricular Dev · HeartMate II LVAS · HeartMate Touch · HeartWare HVAD · INJECTAFER · INSPIRE · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · KENGREAL · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LEXISCAN · LOKELMA · LifeVest · MERLIN@HOME · MULTAQ · Merlin Connectivity and Remote · Mitra Clip system · MitraClip System · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · OPTIS · Occluders · Optimizer · Optimizer Smart System · Ozempic · PANTHERIS · PRADAXA · PRALUENT · Peripheral Orbital Atherectomy System · Pounce Thrombectomy System · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · REVEAL LINQ · ROTABLATOR · Repatha · Resolute · S · Solia · TEGSEDI · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TREPROSTINIL · TYVASO · Temperature Management System · Tendril Pacing Lead · UPTRAVI · VENASEAL · VERQUVO · VYNDAQEL · Vascepa · Veltassa · VenaSeal · Verquvo · WAINUA · WATCHMAN · WATCHMAN FLX · WatchPAT · Wegovy · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in TX.
Equivalent to $7,841 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
2,667
Per 100K population
56.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. George is a clinical cardiology specialist, with above-average Medicare volume (top 8% in TX), and high industry engagement (speaking/promotional, top 0%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. George experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. George performed 1,629 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. George receive payments from pharmaceutical companies?
Yes. Dr. George received a total of $338,883 from 73 companies across 1,260 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. George's costs compare to other internal medicines in Houston?
Dr. George's average Medicare payment per service is $124. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. George) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Houston
Browse internal medicines in Houston ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in TX
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in TX
Which TX internal medicines receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lexicon Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Lexicon Pharmaceuticals, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology